Arbuckle Stuart A's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Feb 14, 2023
- Accession no.
- 0001209191-23-009182
- Filed
- Feb 14, 2023
- Trade date
- Feb 10-13, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions. Open-market sales total $1.46M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Arbuckle Stuart ACIK 0001557290 | Officer (EVP, COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2023 | Common Stock | FTax withholdingDisposed | −3,372 | $294.33 | −$992,480.76 | 92,880 | Direct | |
| Feb 13, 2023 | Common Stock | FTax withholdingDisposed | −5,990 | $298.26 | −$1,786,577.4 | 86,890 | Direct | |
| Feb 13, 2023 | Common Stock | SSaleDisposed | −245 | $296.44F2,F3 | −$72,627.8 | 86,645 | Direct | |
| Feb 13, 2023 | Common Stock | SSaleDisposed | −2,028 | $298.42F2,F4 | −$605,195.76 | 84,617 | Direct | |
| Feb 13, 2023 | Common Stock | SSaleDisposed | −1,779 | $299.26F2,F5 | −$532,383.54 | 82,838 | Direct | |
| Feb 13, 2023 | Common Stock | SSaleDisposed | −835 | $300.13F2,F6 | −$250,608.55 | 82,003 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 4 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $296.44 (range $295.84 to $296.57).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $298.42 (range $297.85 to $298.80).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $299.26 (range $298.86 to $299.81).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $300.13 (range $299.93 to $300.53).
Referenced by the price of 1 transaction in Table I.